RE:RE:Response from fred to my questions.Obviously, Fred won't over promise on revenu. If he did, people would say he is pumping.
I'd rather his answer and make my own calculation based on production capacity for IVIG as IVIG will be sold in bulk without the need of marketing effort.
About Plasminogen, Prometic has a good estimation of the PgCD market, However, there is a potential larger market as Plasminogen healing effect are known in the medical world, especialy in the top tier hospital. And guess what, this is where PgCD is normally treated and this is where the marketing team is concentrating it's efforts.
After one year on the market for Pg, we could be surprised by the quantity of PG sold.
And for the BLA, it is not a matter of if, but when it will be approved. And I am confident that the regulatory timeframe for the approval will be respected for reasons I have already discuss in previous post.
This is summertime, unless there is a US market correction , I am confident that the next 3 months will bring the share price back to new high.